about
The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer ProgressionDysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic AgentsMesothelioma tumor cells modulate dendritic cell lipid content, phenotype and functionThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Gangliosides drive the tumor infiltration and function of myeloid-derived suppressor cells.Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer.Antibody-based immunotherapy in high-risk neuroblastoma.Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells.Lipid glycosylation: a primer for histochemists and cell biologists.Detection of Naturally Occurring Human Antibodies Against Gangliosides by ELISA.Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells.Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor.Endogenous immune response to gangliosides in patients with confined prostate cancer.IFN-γ and tumor gangliosides: Implications for the tumor microenvironment.Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cellsMilk-Derived GM3 and GD3 Differentially Inhibit Dendritic Cell Maturation and Effector Functionalities
P2860
Q26750877-19F97ECC-F2AD-4CB3-B382-2504EB0B5087Q26771367-197C9F48-183C-4261-A0F8-52D16626F903Q28392070-8E3AC5F4-2868-4BA1-97F5-BA87F81EA720Q30317628-A8C63997-3EDA-42FF-896A-5C5C495A6DEFQ34288047-E502DEF4-6CC1-4AC2-8D93-8F58BEEEAC5EQ34449304-EE90BFA7-F945-4BA7-AAF7-8AAFF58A6916Q34725758-7A359BC7-856C-4712-AA42-9A01A558AF5BQ35799094-CABF7AD1-F102-4D08-9719-C48CA218FC00Q36410563-A6625CFB-CC10-4A9D-B051-C2FF39B9CA59Q36962406-287C5B03-5E39-4FBD-BC51-9069F69F12F2Q39045114-1BC6D777-0C9A-4933-8BF2-83FB2248F03DQ40151254-E2FB7A11-6A58-4A36-A35E-0533B84B2EF4Q40440515-AB78A81C-5ED8-4C9E-A858-282F5BC34FB1Q40583922-4728E0D0-E0E4-4990-A605-847DBAFD7F92Q46428450-E0CC29B0-635F-43BB-911F-54B41027DFC1Q50867715-559E3621-E915-4CFB-9322-48B1B4A35CC3Q57356994-727E4F80-844F-4AA3-904F-597431CDBB41Q57578308-E496870F-76E6-4AB0-AC74-CAA3D57B4AFB
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mechanisms of ganglioside inhibition of APC function.
@ast
Mechanisms of ganglioside inhibition of APC function.
@en
type
label
Mechanisms of ganglioside inhibition of APC function.
@ast
Mechanisms of ganglioside inhibition of APC function.
@en
prefLabel
Mechanisms of ganglioside inhibition of APC function.
@ast
Mechanisms of ganglioside inhibition of APC function.
@en
P2093
P2860
P1476
Mechanisms of ganglioside inhibition of APC function.
@en
P2093
Andreas Heitger
Barbara Taylor
Sheila Caldwell
Stephan Ladisch
Weiping Shen
P2860
P304
P356
10.4049/JIMMUNOL.171.4.1676
P407
P577
2003-08-01T00:00:00Z